Clinical trial · Observational
Sexual Functioning After Primary Treatment of Ovarian Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Lack of accrual
Summary
Brief summary (as posted)
The purpose of this study is to help us learn more about sexual problems after treatment for ovarian cancer. At this time, we do not know how many women have sexual problems after they are treated for ovarian cancer. How common are sexual problems after treatment for ovarian cancer? * What factors make women more likely to have sexual problems after treatment for ovarian cancer? * What happens to sexual functioning over the first 12 months after treatment? ie. Does it get better or worse? • Does referral to a specialized sexual health clinic help?
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ovarian Cancer | Malignant Ovarian Neoplasm | CURATED_EXACT | 0.92 |
| Sexual Dysfunction | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| questionnaires | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- 1
- description
- FSFI score \<= 26
- interventionNames
- Behavioral: questionnaires
- label
- 2
- description
- FSFI score \>26
- interventionNames
- Behavioral: questionnaires
Primary outcomes (1)
- measure
- To estimate the prevalence of sexual dysfunction, as measured by Female Sexual Functioning Index (FSFI) among women who have completed first-line treatment for ovarian cancer within the last 6 months and currently have no evidence of disease.
- timeFrame
- conclusion of study
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Women with any stage of invasive epithelial ovarian cancer who have completed frontline therapy within the past 6 months * Women must have no clinical evidence of disease * At least 18 years of age * English speaking * Able to participate in the informed consent process * Women who present to Sexual Health Clinic for the first time and meet all other eligibility criteria are eligible. Their FSFI scores will be used to determine the primary endpoint of prevalence of sexual dysfunction. If they score over 26 on the FSFI, they may still elect to be followed at the SHC. Exclusion Criteria: * Active secondary cancer requiring cytotoxic chemotherapy at the time enrollment * Evidence of recurrent/persistent disease by elevated CA125, findings on imaging (CT, PET scan etc) or physical examination * Women with borderline (low malignant potential) ovarian cancers * Women who are already in active evaluation and/or follow-up at the Sexual Health Clinic * Women with a history of prior whole pelvic radiation
References
Publications (0)
Data not yet available